Stock Market News: Economy, Policy & Company Updates
EquityTimer summarises official corporate filings and market announcements into short, factual updates you can read in seconds. Every card is drawn directly from primary sources — BSE corporate announcements in India and SEC filings in the US — covering results, dividends, mergers, management changes and regulatory actions. Summaries are checked against the original document before publication, and each card links back to the filing so you can read it in full.
Oracle posts record Q1 FY27 revenue of $19.3 billion, GAAP EPS $1.56
Oracle reported record Q1 FY27 revenue of $19.3 billion, a 30% increase, with total cloud revenue reaching $11.6 billion, up 62%, and cloud infrastructure revenue soaring 121% to $7.4 billion. GAAP net income rose 60% to $4.7 billion, GAAP EPS to $1.56, non‑GAAP EPS to $1.92, operating cash flow hit $23 billion, and the board declared a $0.50 per share quarterly dividend.
Adobe reported record Q3 FY2026 revenue of $6.76 billion
Adobe announced third‑quarter FY2026 revenue of $6.76 billion, up 13% year over year, and GAAP diluted earnings per share of $4.62. The company’s recurring revenue reached $27.50 billion, cash flow from operations was $2.52 billion, and it repurchased about 9.5 million shares. Adobe also reported GAAP operating income of $2.35 billion, non‑GAAP operating income of $2.97 billion, and topped 1 billion monthly active users.
GSK reports President Maya Martinez‑Davis bought 9.837 ADS at $48.5400 each
GSK plc disclosed that President Maya Martinez‑Davis acquired 9.837 American Depositary Shares of GSK at $48.5400 per share on September 8, 2026 through her Executive Supplemental Savings Plan. The transaction was executed on the New York Stock Exchange and reported in a Form 6‑K filing dated September 10, 2026. The filing also listed GSK’s Legal Entity Identifier as 5493000HZTVUYLO1D793 in the United States.
HSBC CFO Pam Kaur to retire by 2027 AGM, will serve as adviser thereafter
HSBC announced that Group CFO Pam Kaur will step down no later than the 2027 Annual General Meeting and will not stand for re‑election as a director. She will remain in her role and on the board until the AGM, then serve as an adviser to the Group CEO through the end of 2028. The board has begun a search for her successor.
TSMC reports August 2026 net revenue of NT$514.81 billion, up 10.1% MoM and 53.3% YoY
TSMC disclosed that net revenue for August 2026 was NT$514.81 billion, a 10.1 percent increase from July 2026 and 53.3 percent higher than August 2025. For the January‑August 2026 period, total revenue reached NT$3,386.87 billion, up 39.3 percent year‑over‑year. It reported NT$3.80 billion outstanding loans to its subsidiary TSMC Development and NT$2.57 billion in guarantees for TSMC North America.
Barclays COO Craig Bright sold 65,500 shares at £4.873 each
Barclays PLC disclosed that Group Co‑Chief Operating Officer and Barclays Execution Services Co‑Chief Executive Officer Craig Bright disposed of 65,500 ordinary shares at a price of £4.873 per share. The transaction was executed by Computershare Investor Services plc as administrator of Barclays’ nominee service on the London Stock Exchange on September 9, 2026 and recorded in the filing.
GSK awarded 10,050 ordinary shares to executives under 2025 Share Value Plan
GSK plc disclosed that on September 8, 2026 it awarded ordinary shares valued at £17.9650 each, totaling 10,050 shares, to Victoria Whyte, SVP & Company Secretary, and to Neil Falkingham, PCA of Lynn Baxter. The shares were issued under the company's 2025 Share Value Plan and were recorded in a Form 6‑K filing as a single transaction.
Barclays reports transfer of 1.17 million shares and 217,182 ADSs to CEO's spouse
Barclays PLC disclosed that on September 4, 2026 it transferred 1,173,990 ordinary shares (GB0031348658) and 217,182 American Depositary Shares (US06738E2046) from a joint account held by Group Chief Executive C.S. Venkatakrishnan and his PCA, P. Venkatakrishnan, to an account solely in P. Venkatakrishnan’s name. Both transactions were executed outside a trading venue. The filings were made in a Form 6‑K on September 8, 2026.
GameStop posts Q2 operating income of $160.2 million, lifts FY2026 Adjusted EBITDA outlook
GameStop Corp. disclosed that second‑quarter net sales were $790.2 million, with collectibles sales rising 57% to $356.3 million, representing 45.1% of net sales. Operating income reached $160.2 million, the highest Q2 ever, and adjusted EBITDA was $174.0 million. The company raised its fiscal‑year 2026 Adjusted EBITDA outlook to over $650 million. It held $5.4 billion in cash, equivalents, marketable securities and digital assets.
GSK reports Q2 2026 sales of £8.4 billion, up 5% year‑over‑year
GlaxoSmithKline disclosed second‑quarter 2026 sales of £8.4 billion, a 5% increase on a reported basis. The filing highlighted acquisitions of two late‑stage lung‑cancer medicines, positive phase‑III data for several candidates, and the launch of an Accelerate Growth programme targeting £1.9 billion of annual savings by 2029. GSK said it has 62 assets, with seven accelerations across 18 indications and expects to start 20 phase‑III trials in 2026.
Oracle posts record Q1 FY27 revenue of $19.3 billion, GAAP EPS $1.56
Oracle reported record Q1 FY27 revenue of $19.3 billion, a 30% increase, with total cloud revenue reaching $11.6 billion, up 62%, and cloud infrastructure revenue soaring 121% to $7.4 billion. GAAP net income rose 60% to $4.7 billion, GAAP EPS to $1.56, non‑GAAP EPS to $1.92, operating cash flow hit $23 billion, and the board declared a $0.50 per share quarterly dividend.
Adobe reported record Q3 FY2026 revenue of $6.76 billion
Adobe announced third‑quarter FY2026 revenue of $6.76 billion, up 13% year over year, and GAAP diluted earnings per share of $4.62. The company’s recurring revenue reached $27.50 billion, cash flow from operations was $2.52 billion, and it repurchased about 9.5 million shares. Adobe also reported GAAP operating income of $2.35 billion, non‑GAAP operating income of $2.97 billion, and topped 1 billion monthly active users.
GSK reports President Maya Martinez‑Davis bought 9.837 ADS at $48.5400 each
GSK plc disclosed that President Maya Martinez‑Davis acquired 9.837 American Depositary Shares of GSK at $48.5400 per share on September 8, 2026 through her Executive Supplemental Savings Plan. The transaction was executed on the New York Stock Exchange and reported in a Form 6‑K filing dated September 10, 2026. The filing also listed GSK’s Legal Entity Identifier as 5493000HZTVUYLO1D793 in the United States.
HSBC CFO Pam Kaur to retire by 2027 AGM, will serve as adviser thereafter
HSBC announced that Group CFO Pam Kaur will step down no later than the 2027 Annual General Meeting and will not stand for re‑election as a director. She will remain in her role and on the board until the AGM, then serve as an adviser to the Group CEO through the end of 2028. The board has begun a search for her successor.
TSMC reports August 2026 net revenue of NT$514.81 billion, up 10.1% MoM and 53.3% YoY
TSMC disclosed that net revenue for August 2026 was NT$514.81 billion, a 10.1 percent increase from July 2026 and 53.3 percent higher than August 2025. For the January‑August 2026 period, total revenue reached NT$3,386.87 billion, up 39.3 percent year‑over‑year. It reported NT$3.80 billion outstanding loans to its subsidiary TSMC Development and NT$2.57 billion in guarantees for TSMC North America.
Barclays COO Craig Bright sold 65,500 shares at £4.873 each
Barclays PLC disclosed that Group Co‑Chief Operating Officer and Barclays Execution Services Co‑Chief Executive Officer Craig Bright disposed of 65,500 ordinary shares at a price of £4.873 per share. The transaction was executed by Computershare Investor Services plc as administrator of Barclays’ nominee service on the London Stock Exchange on September 9, 2026 and recorded in the filing.
GSK awarded 10,050 ordinary shares to executives under 2025 Share Value Plan
GSK plc disclosed that on September 8, 2026 it awarded ordinary shares valued at £17.9650 each, totaling 10,050 shares, to Victoria Whyte, SVP & Company Secretary, and to Neil Falkingham, PCA of Lynn Baxter. The shares were issued under the company's 2025 Share Value Plan and were recorded in a Form 6‑K filing as a single transaction.
Barclays reports transfer of 1.17 million shares and 217,182 ADSs to CEO's spouse
Barclays PLC disclosed that on September 4, 2026 it transferred 1,173,990 ordinary shares (GB0031348658) and 217,182 American Depositary Shares (US06738E2046) from a joint account held by Group Chief Executive C.S. Venkatakrishnan and his PCA, P. Venkatakrishnan, to an account solely in P. Venkatakrishnan’s name. Both transactions were executed outside a trading venue. The filings were made in a Form 6‑K on September 8, 2026.
GameStop posts Q2 operating income of $160.2 million, lifts FY2026 Adjusted EBITDA outlook
GameStop Corp. disclosed that second‑quarter net sales were $790.2 million, with collectibles sales rising 57% to $356.3 million, representing 45.1% of net sales. Operating income reached $160.2 million, the highest Q2 ever, and adjusted EBITDA was $174.0 million. The company raised its fiscal‑year 2026 Adjusted EBITDA outlook to over $650 million. It held $5.4 billion in cash, equivalents, marketable securities and digital assets.
GSK reports Q2 2026 sales of £8.4 billion, up 5% year‑over‑year
GlaxoSmithKline disclosed second‑quarter 2026 sales of £8.4 billion, a 5% increase on a reported basis. The filing highlighted acquisitions of two late‑stage lung‑cancer medicines, positive phase‑III data for several candidates, and the launch of an Accelerate Growth programme targeting £1.9 billion of annual savings by 2029. GSK said it has 62 assets, with seven accelerations across 18 indications and expects to start 20 phase‑III trials in 2026.
enGene Therapeutics reports Q3 2026 results, $266.3 million cash and plans BLA filing
enGene Therapeutics Inc. disclosed third‑quarter 2026 financial results, reporting $266.3 million in cash, cash equivalents and marketable securities and total operating expenses of $34.0 million. The company highlighted an interim 54% complete response rate for detalimogene in LEGEND Cohort 1 and outlined upcoming milestones, including a pre‑BLA meeting and BLA filing in Q4 2026. The company cleared a surfactant run‑in and will host an Oct. 15 webinar on the data.
Li Auto filed Form 6‑K to disclose its 2026 interim report
Li Auto Inc. submitted a Form 6‑K on September 8, 2026, providing its interim report for the first six months of the fiscal year ending December 31, 2026 as Exhibit 99.1. The filing was signed by Director and CFO Tie Li.
BHP Responds to Media Speculation on Western Australia Iron Ore Partnership
BHP Group Limited issued a Form 6‑K on September 4, 2026 addressing recent media speculation about a possible partnership involving its Western Australia Iron Ore (WAIO) business. The company emphasized its long history of asset partnerships, affirmed that WAIO remains central to its portfolio, and reiterated its full commitment to the WAIO operation and Western Australia.